University of Kansas Cancer Center - Briarcliff — Kansas City, Missouri

University of Kansas Cancer Center - Briarcliff is a clinical research site located in Kansas City, Missouri, United States 64116.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Kansas Cancer Center - Briarcliff has participated in 35 clinical trials with 34 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Extensive Stage Lung Small Cell Carcinoma.

Sponsors: National Cancer Institute (NCI), SWOG Cancer Research Network, NRG Oncology.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Kansas Cancer Center - Briarcliff?

University of Kansas Cancer Center - Briarcliff has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Kansas Cancer Center - Briarcliff conducted?

University of Kansas Cancer Center - Briarcliff has 35 clinical trials on record, with 34 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Extensive Stage Lung Small Cell Carcinoma.

Is University of Kansas Cancer Center - Briarcliff accredited by Crixeo Health?

Yes — University of Kansas Cancer Center - Briarcliff holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Kansas Cancer Center - Briarcliff?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.